₹34.65
(Inclusive of all Taxes)
Get Free delivery (₹99) with



Lignowin 21.3mg Injection is indicated for the production of regional or local anaesthesia during surgery or medical procedures. Additionally, it is indicated in the management of ventricular arrhythmia (abnormal heartbeat) associated with acute myocardial infarction or cardiac surgery.
Lignowin 21.3mg Injection contains Lidocaine, which works by preventing initiation and conduction of impulses; hence providing an anaesthetic effect. Lignowin 21.3mg Injection blocks cardiac sodium channels, thereby treating arrhythmia.
In some cases, you may experience side effects such as dizziness, high/low blood pressure, nausea, vomiting, and paresthesia (burning or prickling sensation). You are advised to talk to your doctor if you experience these side effects persistently.
Do not take Lignowin 21.3mg Injection if you are allergic to any of its components. Consult your doctor if you are pregnant, planning for pregnancy or breastfeeding. Keep your doctor informed about your health condition and medications to rule out any interactions/side effects.
Lignowin 21.3mg Injection is used to provide local anaesthesia and manage certain heart conditions. The detailed uses of Lignowin 21.3mg Injection include:
Caution
It is not known if alcohol affects Lignowin 21.3mg Injection. Please consult your doctor if you have any concerns regarding this.
Caution
Please consult your doctor if you are pregnant or planning for pregnancy. Your doctor will prescribe only if the benefits outweigh the risks.
Caution
Please consult your doctor if you are breastfeeding. Your doctor will decide if Lignowin 21.3mg Injection can be taken by breastfeeding mothers or not.
Caution
Avoid driving or operating machinery as Lignowin 21.3mg Injection may cause dizziness, drowsiness and loss of sensation.
Caution
Lignowin 21.3mg Injection should be used with caution in patients with liver impairment/liver disease. Please consult your doctor if you have any concerns regarding this.
Caution
Lignowin 21.3mg Injection should be used with caution in patients with kidney impairment/kidney disease. Please consult your doctor if you have any concerns regarding this.
Caution
Limited information is available. Please consult your doctor if you have any concerns regarding the usage of Lignowin 21.3mg Injection in children.
Caution
Lignowin 21.3mg Injection should be used with caution in patients with heart disease. Please consult your doctor if you have any concerns regarding this.
Caution
Lignowin 21.3mg Injection should be used with caution in elderly patients. Please consult your doctor before use.

Have a query?
RXCelon Laboratories Pvt Ltd
₹36.5
(₹1.22/ 1ml)
RXScott Edil Pharmacia Ltd
₹32.25
(₹32.25/ 1ml)
Lignowin 21.3mg Injection is indicated for the production of regional or local anaesthesia during surgery or medical procedures. Additionally, it is indicated in the management of ventricular arrhythmia (abnormal heartbeat) associated with acute myocardial infarction or cardiac surgery.
Lignowin 21.3mg Injection blocks the influx (entry) of sodium ions into the membrane that surrounds the nerves, thereby preventing initiation and conduction of impulses and hence providing an anaesthetic effect. Lignowin 21.3mg Injection blocks cardiac sodium channels, thereby treating arrhythmia.
Lignowin 21.3mg Injection may cause hypotension (low blood pressure) or hypertension (high blood pressure). Therefore, regular monitoring of blood pressure is advised whilst on treatment with Lignowin 21.3mg Injection.
Nausea and vomiting might be side effects of Lignowin 21.3mg Injection. It is not necessary for everyone taking Lignowin 21.3mg Injection to experience these side effects. However, if the condition persists or worsens, please consult a doctor.
Lignowin 21.3mg Injection might increase creatinine phosphokinase levels. Therefore, if you are undergoing any tests, inform the person doing the tests that you have taken Lignowin 21.3mg Injection.
Disclaimer
We provide you with authentic, trustworthy and relevant information